No CrossRef data available.
Article contents
Lamictal
Published online by Cambridge University Press: 18 September 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Other
- Information
- Copyright
- Copyright © Canadian Neurological Sciences Federation 1996
References
1.Goa, KLel al. Lamotrigine: A review of its pharmacological properties and dinical efficacy in epilepsy. Drugs 1993;46(1):152–176.CrossRefGoogle Scholar
2.Leach, MJet al. Neurochemical and behavkxal aspects of lamotrigine. Epilepsia 1991;32(Suppl.2):S4–S8.CrossRefGoogle ScholarPubMed
3. Data on file Glaxo Wellcome (GWMN[2]:09/96).Google Scholar
4.Brodie, MJLamotrigine versus other antiepileptic drugs: A star rating system is born. Epilepsia 1994;35(Suppl.5):S41–46.Google ScholarPubMed
6.Richens, A, Yuen, AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 1991;32(Suppl.2):S13–S16.CrossRefGoogle ScholarPubMed
7.Betts, Tet al. Human safety of lamotrigine. Epilepsia 1991;32(Suppl.2):S17–S21.CrossRefGoogle ScholarPubMed
8.Binnie, CDet al. Acute effects of lamotrigine (BW 430C) in persons with epilepsy. Epilepsia 1986;27(3)248–254.CrossRefGoogle ScholarPubMed
9.Sander, JWASet alA randomised double-blind placebo-controlled add-on trial of lamtrigine in patients with severe epilepsy. Epilepsy Res 1990;6(3):221–226.CrossRefGoogle Scholar
10.Yuen, AWCLamotrigine: A review of antiepileptic efficacy. Epilepsia 1994;35(Suppl.5):S33–S3.CrossRefGoogle ScholarPubMed
11.Binne, CDLamotrigine. Comprehensive Epleptology. New York Raven Press 1990:665–670.Google Scholar
12.Binne, CDet al. Double-blind crossover tiral of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989;4(3)222–229.CrossRefGoogle Scholar
13.Dren, ATet alPlacebo-controlled, dose-response evaluation of the efficacy and safety of motrigine (LAMICTA) as add-on therapy in epileptic outpatients with partial seizures. Epilepsia 1991:32 (Suppl.3)2.Google Scholar
14.Gay, PEet al. Chronic dose tolerance of lamotrigine and placebo in patients with epilepsy. Epilepsia 1988;29(5):686.Google Scholar
15.Jawad, Set al. Controlled trial of lamotrigiie (Lamictal) for refractory partial seizures. Epilepsia 1989;30(3):356–363.CrossRefGoogle ScholarPubMed
16.Loiseau, Pet al. A randomised double-bilnd placebo-controlled crossover add-on trial of lamotrigine it patient with trealment-resistant partial seizures. Epilepsy fles 1990;7(2):136–145.CrossRefGoogle ScholarPubMed
17.Matsuo, Fet al. Placebo-controled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–2291.CrossRefGoogle ScholarPubMed
18.Messenheimer, Jet al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35(1):113–121.CrossRefGoogle ScholarPubMed
19.Mikati, MAet al. Long-term tolerability, pharmacokinetic and preliminary efficacy study of Lamotrigine in patients with resistant partial seizures. Neuropharmacol 1989;12(4):312–321.CrossRefGoogle ScholarPubMed
21.Risner, MEet al. Multicenter, double-blind, placebo-controlled, add-on, crossover study of lamotrigine (Lamictal) in epileptic outpatients with partial seizures. Epilepsia 1990;31(5):619–620.Google Scholar
22.Schapel, GJet al. No effect of lamotrigine on carbamazepine and mazepine-epoxide concentrations. Epilepsia 1991;32 (Suppl.1):58.Google Scholar
23.Smith, Det al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34(2);312–322.CrossRefGoogle ScholarPubMed
26.Cohen, AFet al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;20:619–629.CrossRefGoogle ScholarPubMed
You have
Access